To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Drug Efficacy Study Implementation
Drug Efficacy Study Implementation (DESI) was a program begun by the Food and Drug Administration (FDA) in the 1960s after the requirement that all drugs be efficacious as well as safe. The DESI program was intended to classify all pre-1962 drugs that were already on the market as either effective, uneffective, or needing further study.
Additional recommended knowledge
The DESI program was a consequence of the Kefauver-Harris Drug Control Act.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Drug_Efficacy_Study_Implementation". A list of authors is available in Wikipedia.|